Checkpoint Therapeutics, Inc.
CKPTDelisted May 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651407
Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Checkpoint Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 45 | 2 | 47 | +4 |
| Shares | 5.88M | 218.6K | 7.69M | +2.03M (+36.0%) |
| Value | $12.6M | $469.9K | $17.2M | +$5.07M (+41.6%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 209,583 | $469.5K | 0.00% |
| HB Wealth Management, LLC | 78,000 | $174.7K | 0.00% |
| Walleye Capital LLC | 65,948 | $147.7K | 0.00% |
| Marshall Wace, LLP | 62,703 | $140.5K | 0.00% |
| Virtu Financial LLC | 13,605 | $30.0K | 0.00% |
| Citadel Advisors LLC | 13,116 | $29.4K | 0.00% |
| Golden State Equity Partners | 340 | $761 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 200 | $0 | 0.00% |
Sold out (4)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| National Asset Management, Inc. | 229,200 | $492.8K |
| Millennium Management LLC | 39,212 | $84.3K |
| HRT Financial LP | 21,329 | $45.0K |
| VisionPoint Advisory Group, LLC | 100 | $215 |
Not filed for Q3 2024 yet (2)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 202,860 | $436.1K |
| Emfo, LLC | 15,715 | $33.8K |